Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines
- 15 August 1995
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 41 (6) , 828-835
- https://doi.org/10.1002/jnr.490410613
Abstract
L-Huperzine-A (Hup-A), a natural cholinesterase inhibitor (ChEI) derived from the Chinese herb Huperzia serrata, was administered systemically (i.p.) or locally through the microdialysis probe into the rat cortex. Systemic Hup-A significantly increased acetylcholine (ACh) levels above baseline at doses of 0.1, 0.3, and 0.5 mg/kg; the increases were 54%, 129%, and 220%, respectively. Norepinephrine (NE) and dopamine (DA) levels were also increased 121% and 129% above baseline at 0.3 mg/kg, and 143% and 153% at 0.5 mg/kg. Peak cholinesterase (ChE) inhibition was 23% at 60 min with the 0.3 mg/kg dose. Huperzine-A, perfused through the microdialysis probe, produced a maximal increase of ACh levels of 3090% and 7790% at concentrations of 5 and 50 μM. The ACh increase seen at both concentrations lasted at least 6 hr. At the 5-μM dose, NE and DA were increased by 214% and 386%; at the 50-μM dose, NE and DA were increased by 216% and 1141%. There were no changes of 5-HT levels. With local administration (via the probe), both doses produced facialforelimb seizures that lasted throughout the perfusion. Our results show that Hup-A is a potent inhibitor of ChE which penetrates into the brain and produces a dose-dependent increase of ACh, NE, and DA in rat cortex. This effect is seen with both systemic and local intracerebral administration, suggesting cortical as well as subcortical effects of the drug.Keywords
This publication has 26 references indexed in Scilit:
- Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortexNeuropharmacology, 1993
- Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatumNeuropharmacology, 1993
- Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalisNeuropharmacology, 1990
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- Pharmacokinetics and pharmacodynamics of acetylcholinesterase inhibition: Can acetylcholine levels in the brain be improved in alzheimer's disease?Drug Development Research, 1988
- Muscarinic receptor activation inhibits both release and synthesis of noradrenaline in rat hippocampal synaptosomesNeurochemistry International, 1986
- The role of dopamine in locomotor activity and learningBrain Research Reviews, 1983
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalisAnnals of Neurology, 1981
- Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus MonkeyScience, 1979